DanielStephanPrattMD

PubMed

• 53 citations
  Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.
  Oren K. Fix, Bilal Hameed, Robert J. Fontana, Ryan M. Kwok, Brendan M. McGuire, David C. Mulligan, Daniel S. Pratt, Mark W. Russo, Michael L. Schilsky, Elizabeth C. Ve...> ;Hepatology. 2020 Jul 1
• 5 citations
  Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning.
  Emily D. Bethea, Ashwini Arvind, Jenna L. Gustafson, Karin L. Andersson, Daniel S. Pratt, Irun Bhan, Michael Thiim, Kathleen E. Corey, Patricia P. Bloom, J. Markmann, ...> ;American Journal of Transplantation. 2020 Jun 1
• Myelofibrosis and Portal Hypertension: The Case for Primary Variceal Screening.
  Marc S. Sherman, Wesley R Samore, Daniel S. Pratt> ;ACG Case Reports Journal. 2020 Mar 2
• 6 citations
  Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.
  Kate D. Lynch, Roger W. Chapman, Satish Keshav, Aldo J. Montano-Loza, Andrew L. Mason, Andreas E. Kremer, Marcel Vetter, Manon de Krijger, Cyriel Y. Ponsioen, Palak J....> ;Clinical Gastroenterology and Hepatology. 2020 Jan 1
• 16 citations
  Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study
  Emily D. Bethea, Kerry Gaj, Jenna L. Gustafson, Andrea L. Axtell, Taylor A. Lebeis, Mark Schoenike, Karen Turvey, Erin Coglianese, Sunu S. Thomas, Christopher Newton-C...> ;The Lancet Gastroenterology & Hepatology. 2019 Oct 1
• 16 citations
  Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.
  Jessica R. Allegretti, Zain Kassam, Madeline Carrellas, Benjamin H. Mullish, Julian R. Marchesi, Alexandros Pechlivanis, Mark Smith, Ylaine Gerardin, Sonia Timberlake,...> ;The American Journal of Gastroenterology. 2019 Jul 1
• The Role of Bezafibrate, a Peroxisome Proliferator-Activated Receptor Alpha Agonist, in Patients With Primary Biliary Cholangitis.
  Daniel S. Pratt> ;Hepatology. 2019 Jun 1
• Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement.
  Andrew S. Allegretti, Nathan E. Frenk, Darrick K. Li, Harish Seethapathy, Xavier Vela Parada, Joshua Long, Paul Endres, Daniel S. Pratt, Raymond T. Chung, Suvranu Gang...> ;PLOS ONE. 2019 May 23
• Primary Sclerosing Cholangitis Is Not Rare Among Blacks in a Multicenter North American Consortium
  David S. Goldberg, Cynthia Levy, Kidist Yimam, Stuart C. Gordon, Lisa M. Forman, Elizabeth C. Verna, Lei Yu, Robert S. Rahimi, Kathleen B. Schwarz, Bertus Eksteen, Dan...> ;Clinical Gastroenterology and Hepatology. 2017 Nov 1
• Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis.
  Sumeyye Samur, Matthew J. Klebanoff, Reiner Banken, Daniel S. Pratt, Rick Chapman, Daniel A. Ollendorf, Anne M. Loos, Kathleen E. Corey, Chin Hur, Jagpreet Chhatwal> ;Hepatology. 2017 Mar 1
• Time to update radiological criteria for non-invasive diagnosis of hepatocellular carcinoma
  Sanjay Saini, Daniel S. Pratt> ;Hepatology International. 2015 Jan 1
• Widespread Morbilliform Eruption Associated With Telaprevir: Use of Dermatologic Consultation to Increase Tolerability
  Lauren Strazzula, Daniel S. Pratt, Janet Zardas, Raymond T. Chung, Michael Thiim, Daniela Kroshinsky> ;JAMA Dermatology. 2014 Jul 1
• Immunoglobulin g4-associated cholangitis: the next great masquerader.
  Andrew S. deLemos, Daniel S. Pratt> ;Gastroenterología y Hepatología. 2013 Apr 1
• Case records of the Massachusetts General Hospital. Case 22-2012. A 34-year-old man with intractable vomiting after ingestion of an unknown substance.
  Macías Konstantopoulos, W., Burns Ewald, M., Pratt, D. S.> ;N Engl J Med. 2012 Jul 19
• Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis.
  Kathleen E. Corey, Michelle Lai, Louis Gelrud, Joseph Misdraji, Lydia L. Barlow, Hui Zheng, Karin L. Andersson, Michael Thiim, Daniel S. Pratt, Raymond T. Chung> ;Clinical Gastroenterology and Hepatology. 2012 Jun 1
• A histopathologic pattern of centrilobular hepatocyte injury suggests 6-mercaptopurine-induced hepatotoxicity in patients with inflammatory bowel disease.
  Ricard Masia, Daniel S. Pratt, Joseph Misdraji> ;Archives of Pathology & Laboratory Medicine. 2012 May 30
• Autoimmune hepatitis: current challenges in diagnosis and management in a chronic progressive liver disease.
  Esperance A. Schaefer, Daniel S. Pratt> ;Current Opinion in Rheumatology. 2012 Jan 1
• Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis.
  Tobias Mueller, Claudia Beutler, Almudena Hurtado Picó, Oren Shibolet, Daniel S. Pratt, Andreas Pascher, Peter Neuhaus, Bertram Wiedenmann, Thomas Berg, Daniel K. Podo...> ;Liver International. 2011 Nov 1
• IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material.
  Vikram Deshpande, Nisha I. Sainani, Raymond T. Chung, Daniel S. Pratt, Gilles Mentha, Laura Rubbia-Brandt, Gregory Y. Lauwers> ;Modern Pathology. 2009 Oct 1
• Hepatitis B: significant advances and unmet challenges.
  Daniel S. Pratt> ;Current Opinion in Gastroenterology. 2009 May 1
• Painless jaundice with serial multi-organ dysfunction
  Arezou Khosroshahi, James R. Stone, Daniel S. Pratt, Vikram Deshpande, John H. Stone> ;The Lancet. 2009 Apr 25
• Review: Current status of therapy for hepatocellular carcinoma:
  Kathleen E. Corey, Daniel S. Pratt> ;Therapeutic Advances in Gastroenterology. 2009 Jan 1
• Liver disorders.
  Pratt, D.S.> ;Curr Opin Gastroenterol. 2008 May
• Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patients.
  Patrick Yachimski, Daniel S. Pratt> ;Journal of Clinical Gastroenterology. 2008 Feb 1
• Cholestasis and cholestatic syndromes.
  O'Leary, J.G., Pratt, D.S.> ;Curr Opin Gastroenterol. 2007 May
• Join now to see all